Abstract

The title nucleosides (16U, C, G and H) were synthesized from pyrimidine and purine ribonucleosides in about 30% overall yield in 6 steps via key intermediates, protected 3′-deoxy-‘arabino’-nucleosides, which were obtained by deoxygenative [1,2]-hydride shift and β-elimination reactions of sulfonylated ribo-counterparts. Xanthine analogues (9X and 16X) were prepared from the corresponding guanine nucleosides. The unprotected 3′-deoxy-‘arabino’-nucleosides (9U,C,A,G,H,X) and their azido nucleosides 16 did not show any significant activity against either HIV in vitro or P388 leukaemia in mice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.